Group One Trading’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-300
| Closed | -$27 | – | 3650 |
|
|
2023
Q3 | $27 | Hold |
300
| – | – | ﹤0.01% | 1848 |
|
|
2023
Q2 | $28 | Buy |
+300
| New | +$28 | ﹤0.01% | 1727 |
|
|
2022
Q4 | – | Sell |
-190,752
| Closed | -$48K | – | 3666 |
|
|
2022
Q3 | $48K | Sell |
190,752
-36,700
| -16% | -$9.24K | ﹤0.01% | 1245 |
|
|
2022
Q2 | $164K | Buy |
227,452
+7,352
| +3% | +$5.3K | ﹤0.01% | 922 |
|
|
2022
Q1 | $174K | Buy |
220,100
+62,700
| +40% | +$49.6K | ﹤0.01% | 1078 |
|
|
2021
Q4 | $157K | Buy |
157,400
+147,713
| +1,525% | +$147K | ﹤0.01% | 1275 |
|
|
2021
Q3 | $17K | Buy |
9,687
+8,998
| +1,306% | +$15.8K | ﹤0.01% | 1760 |
|
|
2021
Q2 | $1K | Sell |
689
-27,815
| -98% | -$40.4K | ﹤0.01% | 1939 |
|
|
2021
Q1 | $58K | Buy |
28,504
+9,846
| +53% | +$20K | ﹤0.01% | 1343 |
|
|
2020
Q4 | $40K | Sell |
18,658
-4,196
| -18% | -$9K | ﹤0.01% | 1189 |
|
|
2020
Q3 | $62K | Buy |
22,854
+1,104
| +5% | +$3K | ﹤0.01% | 1044 |
|
|
2020
Q2 | $86K | Buy |
+21,750
| New | +$86K | ﹤0.01% | 837 |
|
|
2020
Q1 | – | Sell |
-29,848
| Closed | -$38K | – | 2563 |
|
|
2019
Q4 | $38K | Buy |
29,848
+6,545
| +28% | +$8.33K | ﹤0.01% | 956 |
|
|
2019
Q3 | $16K | Buy |
23,303
+19,403
| +498% | +$13.3K | ﹤0.01% | 1057 |
|
|
2019
Q2 | $2K | Buy |
+3,900
| New | +$2K | ﹤0.01% | 1156 |
|
|
2018
Q3 | – | Sell |
-41
| Closed | – | – | 2426 |
|
|
2018
Q2 | $0 | Hold |
41
| – | – | ﹤0.01% | 2325 |
|
|
2018
Q1 | $0 | Sell |
41
-737
| -95% | – | ﹤0.01% | 2239 |
|
|
2017
Q4 | $6K | Hold |
778
| – | – | ﹤0.01% | 1232 |
|
|
2017
Q3 | $6K | Sell |
778
-440
| -36% | -$3.39K | ﹤0.01% | 1173 |
|
|
2017
Q2 | $12K | Buy |
1,218
+813
| +201% | +$8.01K | ﹤0.01% | 1103 |
|
|
2017
Q1 | $5K | Buy |
+405
| New | +$5K | ﹤0.01% | 1141 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 2082 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 2042 |
|
|
2016
Q2 | – | Sell |
-1,068
| Closed | -$20K | – | 2013 |
|
|
2016
Q1 | $20K | Buy |
+1,068
| New | +$20K | ﹤0.01% | 900 |
|
|
2015
Q4 | – | Sell |
-6,586
| Closed | -$300K | – | 2066 |
|
|
2015
Q3 | $300K | Buy |
6,586
+5,564
| +544% | +$253K | ﹤0.01% | 503 |
|
|
2015
Q2 | $33K | Sell |
1,022
-1,385
| -58% | -$44.7K | ﹤0.01% | 1019 |
|
|
2015
Q1 | $77K | Sell |
2,407
-4,082
| -63% | -$131K | ﹤0.01% | 740 |
|
|
2014
Q4 | $245K | Buy |
6,489
+1,385
| +27% | +$52.3K | ﹤0.01% | 473 |
|
|
2014
Q3 | $135K | Sell |
5,104
-2,268
| -31% | -$60K | ﹤0.01% | 657 |
|
|
2014
Q2 | $218K | Sell |
7,372
-1,203
| -14% | -$35.6K | ﹤0.01% | 524 |
|
|
2014
Q1 | $317K | Buy |
8,575
+3,907
| +84% | +$144K | 0.01% | 441 |
|
|
2013
Q4 | $193K | Buy |
+4,668
| New | +$193K | ﹤0.01% | 582 |
|
|
2013
Q3 | – | Sell |
-1,246
| Closed | -$67K | – | 2064 |
|
|
2013
Q2 | $67K | Buy |
+1,246
| New | +$67K | ﹤0.01% | 772 |
|